Arteris’ (AIP) Buy Rating Reiterated at Rosenblatt Securities

Arteris (NASDAQ:AIP)‘s stock had its “buy” rating reissued by equities researchers at Rosenblatt Securities in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $38.00 target price on the stock. Rosenblatt Securities’ price target points to a potential upside of 20.18% from the company’s previous close.

Other research analysts have also recently issued research reports about the company. Roth Capital initiated coverage on Arteris in a research report on Tuesday. They issued a “buy” rating and a $40.00 price target for the company. Jefferies Financial Group boosted their price objective on shares of Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, May 13th. Weiss Ratings cut shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Wall Street Zen downgraded shares of Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, TD Cowen upped their price target on shares of Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $38.50.

Arteris Price Performance

AIP stock opened at $31.62 on Friday. The firm has a 50 day moving average of $36.06 and a 200-day moving average of $26.16. The company has a market cap of $1.46 billion, a price-to-earnings ratio of -40.03 and a beta of 1.96. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. Arteris has a 12-month low of $8.42 and a 12-month high of $50.26.

Arteris (NASDAQ:AIP) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The company had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. As a group, equities analysts expect that Arteris will post -0.58 EPS for the current fiscal year.

Insider Activity

In other news, major shareholder Bayview Legacy, Llc sold 26,106 shares of Arteris stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $31.97, for a total transaction of $834,608.82. Following the completion of the sale, the insider directly owned 8,329,071 shares in the company, valued at $266,280,399.87. The trade was a 0.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Saiyed Atiq Raza sold 70,000 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $30.01, for a total transaction of $2,100,700.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,498,949 shares of company stock valued at $52,200,293 over the last quarter. 23.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Arteris

Several hedge funds have recently made changes to their positions in AIP. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Arteris in the second quarter valued at $53,000. Versant Capital Management Inc grew its holdings in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after buying an additional 290 shares during the period. Raymond James Financial Inc. purchased a new stake in Arteris in the 2nd quarter valued at about $32,000. State of Wyoming acquired a new position in shares of Arteris during the 2nd quarter valued at about $165,000. Finally, Royal Bank of Canada lifted its holdings in shares of Arteris by 366.7% during the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock worth $66,000 after acquiring an additional 3,161 shares during the period. Institutional investors and hedge funds own 64.36% of the company’s stock.

Key Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported second-quarter revenue of $24.13 million, above the $23.48 million analyst consensus. Management also forecast third-quarter revenue of $24 million to $25 million and full-year revenue of $95 million to $98 million, both ahead of consensus estimates. The improved revenue outlook supports the growth case for Arteris’ semiconductor interconnect and system-IP business. Arteris second-quarter results and guidance
• Positive Sentiment: Roth Capital initiated coverage with a Buy rating and a $40 price target. The recommendation adds to recent bullish analyst coverage, including Oppenheimer’s Outperform rating, and indicates potential upside from recent trading levels. Roth Capital Buy rating
• Neutral Sentiment: Arteris appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, although investors will likely await further details on his priorities and transition. Arteris CFO appointment
• Negative Sentiment: Second-quarter adjusted loss was $0.10 per share, worse than the $0.04–$0.05 consensus loss and only modestly improved from the $0.11 loss a year earlier. The earnings shortfall is the main reason the results could weigh on the stock despite the revenue beat. Arteris second-quarter earnings report
• Negative Sentiment: Insiders reported a cluster of sales, including CEO K. Charles Janac’s sales, Director Saiyed Atiq Raza’s sale of 70,000 shares, and Vice President Paul Alpern’s sale of 4,000 shares. Although insiders retain substantial holdings, the transactions may create a cautious sentiment around AIP. Arteris insider selling

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.